HealthcareServices

Catheter-Related Bloodstream Infection Market Outlook 2026–2030: Key Business Drivers and Trends

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the catheter-related bloodstream infection market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Catheter-Related Bloodstream Infection Market in 2026, and what figure is it projected to hit by 2030?

The catheter-related bloodstream infection market size has shown substantial growth over recent years. It is anticipated to expand from $1.62 billion in 2025 to $1.71 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.0%. The reasons for its historical growth are linked to the increased utilization of central venous catheters, a rise in hospital-acquired infections, the adoption of antibiotic lock therapy, the expansion of intensive care units, and improved clinical understanding of CRBSI.

The market for catheter-related bloodstream infection is projected to experience robust expansion over the coming years, reaching a valuation of $2.11 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.3%. This anticipated growth during the forecast period stems from factors such as heightened investments in strategies for preventing infections, an increasing need for managing antimicrobial resistance, the enlargement of hospital infection control initiatives, greater uptake of combination therapies, and continuous progress in diagnostic technologies. Key trends anticipated for the forecast timeframe involve the expanded utilization of sophisticated antimicrobial lock solutions, a greater embrace of infection surveillance programs, a heightened emphasis on preventing infections acquired in hospitals, the broadening scope of combination antimicrobial treatments, and an increased focus on prompt diagnosis and intervention.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16646&type=smp

Which Drivers Are Affecting Market Participation In The Catheter-Related Bloodstream Infection Market?

The growing occurrence of hospital-acquired infections (HAIs) is anticipated to fuel the expansion of the catheter-related bloodstream infection market. These infections, acquired by patients during treatment in healthcare facilities, typically surface 48 hours or more following admission. Factors such as antimicrobial resistance, inadequate infection control measures, and patient vulnerability contribute to the escalation of HAIs. Catheter-related bloodstream infections are a significant contributor to HAIs because of their invasive nature and potential for microbial colonization, posing dangers to individuals with indwelling catheters. For illustration, in September 2025, data from the National Library of Medicine, a US-based medical library, indicated that in 2024, antimicrobial-resistant organisms (AROs) accounted for 6.6% of infections. Additionally, approximately one-third of healthcare-associated infections (HAIs) were connected to medical devices, and the incidence of central line-associated bloodstream infections (CLABSIs) saw a twofold increase to 0.4%. Consequently, the increasing prevalence of hospital-acquired infections is set to stimulate growth in the catheter-related bloodstream infection market.

What Segment Classifications Make Up The Catheter-Related Bloodstream Infection Market?

The catheter-related bloodstream infection market covered in this report is segmented –

1) By Treatment: Antibiotic Lock Therapy, Anti-Microbial Agents

2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus, Acinetobacter Baumannii, Escherichia Coli (E. Coli), Klebsiella Pneumoniae (K. Pneumonia), Candida Species (Candida Sp.), Pseudomonas Aeruginosa (P. Aeruginosa), Other Source Of Infection Or Causative Agents

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies

Subsegments:

1) By Antibiotic Lock Therapy: Catheter Lock Solutions (Antibiotic-based), Combination Antibiotic Lock Therapy

2) By Anti-Microbial Agents: Antibiotics, Antifungal Agents, Antiseptic Agents

Which Trends Are Influencing The Development Of The Catheter-Related Bloodstream Infection Market?

Prominent companies within the catheter-related bloodstream infection market are innovating catheter lock solutions to bolster infection prevention and improve patient outcomes. A catheter lock solution serves as a liquid introduced into a catheter to deter infections and preserve its patency between uses. As an illustration, in November 2023, CorMedix Inc., a US-based biopharmaceutical company dedicated to developing and commercializing therapeutic products, obtained US Food and Drug Administration approval for DefenCath (taurolidine and heparin) catheter lock solution. This approval covers adult patients experiencing kidney failure who are undergoing chronic hemodialysis through a central venous catheter (CVC). This particular antimicrobial and antifungal solution is formulated to diminish catheter-related bloodstream infections (CRBSIs), leveraging heparin for anticoagulation and taurolidine’s extensive antimicrobial attributes.

Which Major Industry Participants Are Leading The Catheter-Related Bloodstream Infection Market Growth?

Major companies operating in the catheter-related bloodstream infection market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, 3M Company, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company, Viatris Inc., B. Braun Medical Inc., Aurobindo Pharma Limited, Lupin Ltd., Xellia Pharmaceuticals Ltd., SteriMax Inc., Bactiguard AB, Hetero Healthcare Ltd., TauroPharm GmbH, Advacare Pharma, Citus Pharmaceuticals Inc., CorMedix Inc., JoinHub Pharma LLP, IntegraDose Compounding Services LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/catheter-related-bloodstream-infection-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Catheter-Related Bloodstream Infection Market?

North America was the largest region in the catheter-related bloodstream infection market in 2025. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Catheter-Related Bloodstream Infection Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16646&type=smp

Browse Through More Reports Similar to the Global Catheter-Related Bloodstream Infection Market 2026, By The Business Research Company

Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/catheters-global-market-report

Diagnostic Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/diagnostic-catheters-global-market-report

Pediatric Catheter Market Report 2026

https://www.thebusinessresearchcompany.com/report/pediatric-catheter-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795